Journal of Diabetes and Its Complications
Volume 25, Issue 1 , Pages 44-51 , January 2011

New diagnostic tests for diabetic distal symmetric polyneuropathy

  • Nikolaos Papanas

      Affiliations

    • Outpatient Clinic of the Diabetic Foot in the Second Department of Internal Medicine at Democritus University of Thrace, Greece
    • Corresponding Author InformationCorresponding author. Democritus University of Thrace, 68100 Alexandroupolis, Greece. Tel.: +30 6977 544337; fax: +30 25510 74723.
    • ,
  • Dan Ziegler

      Affiliations

    • Institute for Clinical Diabetology, German Diabetes Center at the Heinrich Heine University, Leibniz Center for Diabetes Research and Department of Metabolic Diseases, University Hospital, Düsseldorf, Germany

Received 22 July 2009 ,Revised 13 September 2009 ,Accepted 28 September 2009.

References 

  1. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North–West Diabetes Foot Care Study: Incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabetic Medicine. 2002;19:377–384
  2. Al-Shekhlee A, Chelimsky TC, Preston DC. Review: Small-fiber neuropathy. The Neurologist. 2002;8:237–253
  3. American Diabetes Association and American Academy of Neurology . Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes. 1998;37:1000–1004
  4. Banchellini E, Macchiarini S, Dini V, Rizzo L, Tedeschi A, Scatena A, et al. Use of nanotechnology-designed footsock in the management of preulcerative conditions in the diabetic foot: Results of a single, blind randomized study. The International Journal of Lower Extremity Wounds. 2008;7:82–87
  5. Bilen H, Atmaca A, Akcay G. Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes. Advances in Therapy. 2007;24:1020–1027
  6. Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers. The New England Journal of Medicine. 2004;351:48–55
  7. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care. 2005;28:956–962
  8. Bril V, Perkins BA. Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve studies. Diabetic Medicine. 2002;19:661–666
  9. Chéliout-Héraut F, Zrek N, Khemliche H, Varnet O, Seret-Begue D, Martinez M, et al. Exploration of small fibers for testing diabetic neuropathies. Joint Bone Spine. 2005;72:412–415
  10. Chon S, Kim YS, Oh S, Woo JT, Kim SW, Kim JW, et al. Assessment of diabetic autonomic neuropathy in type 2 diabetic subjects using Neuropad: A new indicator plaster for detection of disturbed sweat secretion. Diabetologia. 2005;48(Suppl 1):A 361
  11. Edmonds M. The diabetic foot, 2003. Diabetes Metabolism Research and Reviews. 2004;20(Suppl 1):S9–S12
  12. Eckhard M, Lengler A, Liersch J, Bretzel RG, Mayser P. Fungal foot infections in patients with diabetes mellitus—Results of two independent investigations. Mycoses. 2007;50(Suppl 2):14–19
  13. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and neurophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–1289
  14. Gozani SN, Fisher MA, Kong X, Megerian JT, Rutkove SB. Electrodiagnostic automation: Principles and practice. Physical Medicine and Rehabilitation Clinics of North America. 2005;16:1015–1032
  15. Herman WH, Kennedy L. Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care. 2005;28:1480–1481
  16. Kong X, Gozani SN, Hayes MT, Weinberg DH. NC-stat sensory nerve conduction studies in the median and ulnar nerves of symptomatic patients. Clinical Neurophysiology. 2006;117:405–413
  17. Kong X, Lesser EA, Megerian JT, Gozani SN. Repeatability of nerve conduction measurements using automation. Journal of Clinical Monitoring and Computing. 2006;20:405–410
  18. Krämer HH, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care. 2004;27:2386–2391
  19. Liatis S, Marinou K, Tentolouris N, Pagoni S, Katsilambros N. Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabetic Medicine. 2007;24:1375–1380
  20. Low PA. Evaluation of sudomotor function. Clinical Neurophysiology. 2004;7:1506–1513
  21. Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia. 2005;48:578–585
  22. Manes C, Mikoudi K, Sossidou E, Pigas G, Karagianni D, Skoutas D, et al. Evaluation of a new indicator plaster in identifying diabetic patients at risk of foot ulceration. Diabetologia. 2004;47(Suppl 1):A 376
  23. Maser RE, Laudadio C, Lenhard MJ, DeCherney GS. A cross-sectional study comparing two quantitative sensory testing devices in individuals with diabetes. Diabetes Care. 1997;20:179–181
  24. Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Research and Clinical Practice. 2001;54:115–128
  25. Paisley AN, Abbott CA, van Schie CHM, Boulton AJM. A comparison of the Neuropen against standard quantitative sensory-threshold measures for assessing peripheral nerve function. Diabetic Medicine. 2002;19:400–405
  26. Papanas N, Papatheodorou K, Christakidis D, Papazoglou D, Giassakis G, Piperidou H, et al. Evaluation of a new indicator test for sudomotor function (Neuropad®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Experimental and Clinical Endocrinology and Diabetes. 2005;113:195–198
  27. Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E. Reproducibility of a new indicator test for sudomotor function (Neuropad®) in patients with type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes. 2005;113:577–581
  28. Papanas N, Gries A, Maltezos E, Zick R. The steel ball-bearing test: A new test for evaluating protective sensation in the diabetic foot. Diabetologia. 2006;49:739–743
  29. Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, et al. Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Experimental and Clinical Endocrinology and Diabetes. 2007;115:58–61
  30. Papanas, N., Papatheodorou, K., Papazoglou, D., Christakidis, D., Monastiriotis, C., & Maltezos, E. (2007). The new indicator test (Neuropad): A valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes. The Diabetes Educator, 33, 257–258, 260, 262.
  31. Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes. 2008;116:135–138
  32. Perkins BA, Grewal J, Ng E, Ngo M, Bril V. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care. 2006;29:2023–2027
  33. Quattrini C, Jeziorska M, Tavakoli M, Begum P, Boulton AJ, Malik RA. The Neuropad test: A visual indicator test for human diabetic neuropathy. Diabetologia. 2008;51:1046–1050
  34. Quattrini C, Jeziorska M, Malik RA. Small fiber neuropathy in diabetes: Clinical consequence and assessment. The International Journal of Lower Extremity Wounds. 2004;3:16–21
  35. Rota E, Quadri R, Fanti E, Isoardo G, Poglio F, Tavella A, et al. Neurophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus. Journal of the Peripheral Nervous System. 2005;10:348–353
  36. Shaw JE, Zimmet PZ, Gries FA, Ziegler D. Epidemiology of diabetic neuropathy. In:  Gries FA,  Cameron NE,  Low PA,  Ziegler D editor. Textbook of diabetic neuropathy. Stuttgart: Thieme; 2003;p. 64–82
  37. Shen J, Cao Y, Han YJ, Luo XR, Xie CH, Li JM, et al. Sweat function evaluation for early diagnosis of diabetic peripheral neuropathy. Nan Fang Yi Ke Da Xue Xue Bao. 2007;27:1210–1212
  38. Smith AG, Ramachandran P, Tripp S, Singleton JR. Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology. 2001;57:1701–1704
  39. Smith AG, Howard JR, Kroll R, Ramachandran P, Hauer P, Singleton JR, et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. Journal of the Neurological Sciences. 2005;228:65–69
  40. Spallone V, Morganti R, Siampli M, Fedele T, D'Amato C, Cacciotti L, et al. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabetic Medicine. 2009;26:686–692
  41. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology. 2003;60:108–111
  42. Tentolouris N, Achtsidis V, Marinou K, Katsilambros N. Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care. 2008;31:236–237
  43. Tentolouris N, Marinou K, Kokotis P, Karanti A, Diakoumopoulou E, Katsilambros N. Sudomotor dysfunction is associated with foot ulceration in diabetes. Diabetic Medicine. 2009;26:302–305
  44. Várkonyi T, Kempler P. Diabetic neuropathy: New strategies for treatment. Diabetes Obesity and Metabolism. 2008;10:99–108
  45. Vileikyte L, Hutchings G, Hollis S, Boulton AJM. The tactile circumferential discriminator: A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care. 1997;20:623–626
  46. Vinik AI, Emley MS, Megerian JT, Gozani SN. Median and ulnar nerve conduction measurements in patients with symptoms of diabetic peripheral neuropathy using the NC-stat system. Diabetes Technology and Therapeutics. 2004;6:816–824
  47. Vinik AI, Kong X, Megerian JT, Gozani SN. Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technology and Therapeutics. 2006;8:654–662
  48. Viswanathan V, Snehalatha C, Seena R, Ramachandran A. Early recognition of diabetic neuropathy: Evaluation of a simple outpatient procedure using thermal perception. Postgraduate Medical Journal. 2002;78:541–542
  49. Waizumi K, Masuda H, Ohtaki H, Tsukamoto K, Sunagawa I. In situ observations of the phase transition among Cobalt (II) dichloride hydrates and crystal structures of the tetra- and hexahydrates. Bulletin of the Chemical Society of Japan. 1990;63:3426–3433
  50. Yagihashi S, Yamagishi S, Wada R. Pathology and pathogenetic mechanisms of diabetic neuropathy: Correlation with clinical signs and symptoms. Diabetes Research and Clinical Practice. 2007;77(Suppl 1):S184–S189
  51. Young JA. Cobalt (II) chloride hexahydrate. Journal of Chemical Education. 2003;80:610
  52. Young MJ, Boulton AJM, MacLeod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36:150–154
  53. Zick R, Schäper T, Deeters U. Early detection of peripheral neuropathy. Measurement of perspiration in the diabetic foot. Klinikarzt. 2003;32:192–194
  54. Ziegler D. Painful diabetic neuropathy: Treatment and future aspects. Diabetes Metabolism Research and Reviews. 2008;24(Suppl 1):S52–S57
  55. Ziegler D, Mayer P, Mühlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1991;34:822–829
  56. Ziegler D, Siekierka-Kleiser E, Meyer B, Schweers M. Validation of a novel screening device (NeuroQuick) for quantitative assessment of small fiber dysfunction as an early feature of diabetic polyneuropathy. Diabetes Care. 2005;28:1169–1174

☆ Conflicts of interest: Both authors have received honoraria for participation in advisory board meetings of Miro, the manufacturer of Neuropad. D.Z. was also a co-owner of a patent on the NeuroQuick.

PII: S1056-8727(09)00097-X

doi: 10.1016/j.jdiacomp.2009.09.006

Journal of Diabetes and Its Complications
Volume 25, Issue 1 , Pages 44-51 , January 2011

Article Tools